JP2024542093A5 - - Google Patents

Info

Publication number
JP2024542093A5
JP2024542093A5 JP2024526572A JP2024526572A JP2024542093A5 JP 2024542093 A5 JP2024542093 A5 JP 2024542093A5 JP 2024526572 A JP2024526572 A JP 2024526572A JP 2024526572 A JP2024526572 A JP 2024526572A JP 2024542093 A5 JP2024542093 A5 JP 2024542093A5
Authority
JP
Japan
Prior art keywords
influenza virus
recombinant influenza
recombinant
derived
immunogenic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024526572A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024542093A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/079274 external-priority patent/WO2023081798A1/en
Publication of JP2024542093A publication Critical patent/JP2024542093A/ja
Publication of JP2024542093A5 publication Critical patent/JP2024542093A5/ja
Pending legal-status Critical Current

Links

JP2024526572A 2021-11-05 2022-11-04 組換えヘマグルチニン及びノイラミニダーゼを含む多価インフルエンザワクチン、並びにその使用方法 Pending JP2024542093A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163276284P 2021-11-05 2021-11-05
US63/276,284 2021-11-05
PCT/US2022/079274 WO2023081798A1 (en) 2021-11-05 2022-11-04 Multivalent influenza vaccines comprising recombinant hemagglutinin and neuraminidase and methods of using the same

Publications (2)

Publication Number Publication Date
JP2024542093A JP2024542093A (ja) 2024-11-13
JP2024542093A5 true JP2024542093A5 (https=) 2025-11-11

Family

ID=84462874

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024526572A Pending JP2024542093A (ja) 2021-11-05 2022-11-04 組換えヘマグルチニン及びノイラミニダーゼを含む多価インフルエンザワクチン、並びにその使用方法

Country Status (10)

Country Link
US (1) US20240277828A1 (https=)
EP (1) EP4426346A1 (https=)
JP (1) JP2024542093A (https=)
KR (1) KR20240105412A (https=)
CN (1) CN118201635A (https=)
AU (1) AU2022379948A1 (https=)
CA (1) CA3237134A1 (https=)
IL (1) IL312545A (https=)
MX (1) MX2024005483A (https=)
WO (1) WO2023081798A1 (https=)

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4270537A (en) 1979-11-19 1981-06-02 Romaine Richard A Automatic hypodermic syringe
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
CA1283827C (en) 1986-12-18 1991-05-07 Giorgio Cirelli Appliance for injection of liquid formulations
GB8704027D0 (en) 1987-02-20 1987-03-25 Owen Mumford Ltd Syringe needle combination
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4940460A (en) 1987-06-19 1990-07-10 Bioject, Inc. Patient-fillable and non-invasive hypodermic injection device assembly
US5339163A (en) 1988-03-16 1994-08-16 Canon Kabushiki Kaisha Automatic exposure control device using plural image plane detection areas
FR2638359A1 (fr) 1988-11-03 1990-05-04 Tino Dalto Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5190521A (en) 1990-08-22 1993-03-02 Tecnol Medical Products, Inc. Apparatus and method for raising a skin wheal and anesthetizing skin
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
GB9118204D0 (en) 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
SE9102652D0 (sv) 1991-09-13 1991-09-13 Kabi Pharmacia Ab Injection needle arrangement
US5328483A (en) 1992-02-27 1994-07-12 Jacoby Richard M Intradermal injection device with medication and needle guard
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
US5569189A (en) 1992-09-28 1996-10-29 Equidyne Systems, Inc. hypodermic jet injector
US5334144A (en) 1992-10-30 1994-08-02 Becton, Dickinson And Company Single use disposable needleless injector
US5976552A (en) 1995-04-28 1999-11-02 Protein Sciences Corporation Virus vaccines
US5762939A (en) 1993-09-13 1998-06-09 Mg-Pmc, Llc Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
WO1995024176A1 (en) 1994-03-07 1995-09-14 Bioject, Inc. Ampule filling device
US5466220A (en) 1994-03-08 1995-11-14 Bioject, Inc. Drug vial mixing and transfer device
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
EP1167379A3 (en) 1994-07-15 2004-09-08 University Of Iowa Research Foundation Immunomodulatory oligonucleotides
US5599302A (en) 1995-01-09 1997-02-04 Medi-Ject Corporation Medical injection system and method, gas spring thereof and launching device using gas spring
US5730723A (en) 1995-10-10 1998-03-24 Visionary Medical Products Corporation, Inc. Gas pressured needle-less injection device and method
US5893397A (en) 1996-01-12 1999-04-13 Bioject Inc. Medication vial/syringe liquid-transfer apparatus
GB9607549D0 (en) 1996-04-11 1996-06-12 Weston Medical Ltd Spring-powered dispensing device
WO1998037919A1 (en) 1997-02-28 1998-09-03 University Of Iowa Research Foundation USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
US5993412A (en) 1997-05-19 1999-11-30 Bioject, Inc. Injection apparatus
EP1003531B1 (en) 1997-05-20 2007-08-22 Ottawa Health Research Institute Processes for preparing nucleic acid constructs
IT1298087B1 (it) 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
AU760549B2 (en) 1998-04-03 2003-05-15 University Of Iowa Research Foundation, The Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
CA2659574C (en) 2006-08-02 2017-04-25 The Uab Research Foundation Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity
CA3028175C (en) 2009-12-28 2022-05-24 Sanofi Vaccine Technologies, S.A.S. Methods of producing heterologous viral neuraminidase proteins in microalgae
WO2011126370A1 (en) 2010-04-09 2011-10-13 Universiteit Utrecht Holding B.V. Recombinant multimeric influenza proteins
EP2822585B1 (en) * 2012-03-06 2017-05-17 Janssen Vaccines & Prevention B.V. Improved vaccination against influenza
EP3157557A1 (en) * 2014-06-20 2017-04-26 The U.S.A. as represented by the Secretary, Department of Health and Human Services Polyvalent influenza virus-like particles (vlps) and use as vaccines
GB2552271B (en) 2014-12-19 2020-10-21 Aberystwyth Univ A method for diagnosing lung cancer
US12521430B2 (en) * 2018-03-28 2026-01-13 Sanofi Pasteur Inc. Methods of generating broadly protective vaccine compositions comprising neuraminidase
WO2021080999A1 (en) 2019-10-21 2021-04-29 Sanofi Pasteur, Inc. Systems and methods for predicting biological responses
WO2021080990A1 (en) 2019-10-21 2021-04-29 Sanofi Pasteur, Inc. Systems and methods for designing vaccines
AU2021367917A1 (en) 2020-10-28 2023-06-22 Sanofi Pasteur Liposomes containing tlr4 agonist, preparation and uses thereof

Similar Documents

Publication Publication Date Title
Zheng et al. Development of universal influenza vaccines based on influenza virus M and NP genes
Lee et al. New vaccines against influenza virus
Ebrahimi et al. In contrast to conventional inactivated influenza vaccines, 4xM2e. HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran
Koraka et al. A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice
Noh et al. Influenza vaccines: unmet needs and recent developments
Bertran et al. Expression of H5 hemagglutinin vaccine antigen in common duckweed (Lemna minor) protects against H5N1 high pathogenicity avian influenza virus challenge in immunized chickens
HRP20171213T1 (hr) Glikoproteinske čestice nalik virusu (vlp) bjesnoće
KR102604877B1 (ko) 감염성 질환의 예방 및/또는 치료와 종양학적 질환의 치료를 위한 약독화된 인플루엔자 벡터
JP2016106093A (ja) インフルエンザワクチンの製造方法
Kyriakis et al. Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs
Jazi et al. In vivo electroporation enhances immunogenicity and protection against influenza A virus challenge of an M2e-HSP70c DNA vaccine
US20070116717A1 (en) Influenza vaccine compositions and methods
JP5918870B2 (ja) インフルエンザに対する改善されたワクチン接種
Xie et al. Platycodin D Improves the Immunogenicity of Newcastle Disease Virus‐Based Recombinant Avian Influenza Vaccine in Mice
Ben-Yehuda et al. Recombinant vaccinia virus expressing the PR/8 influenza hemagglutinin gene overcomes the impaired immune response and increased susceptibility of old mice to influenza infection
WO2011024748A1 (ja) インフルエンザm2由来の改変ペプチドワクチン
JP2011524372A (ja) インフルエンザワクチン接種のための新規ペプチドアジュバント
JP2024542093A5 (https=)
KR102732432B1 (ko) 인플루엔자에 대한 면역원성 조성물
Kesik-Brodacka et al. A universal flu vaccine
Luo et al. The virus-induced signaling adaptor molecule enhances DNA-raised immune protection against H5N1 influenza virus infection in mice
WO2014015287A2 (en) Compositions, methods and uses for poxvirus elements in vaccine constructs against influenza virus subtypes or strains
RU2024114703A (ru) Поливалентные вакцины против гриппа, содержащие рекомбинантные гемагглютинин и нейраминидазу, и способы их применения
Khodamoradi et al. IRES-based co-expression of influenza virus conserved genes can promote synergistic antiviral effects both in vitro and in vivo
Qiao et al. H5N1 influenza virus-like particles based on BEVS induce robust functional antibodies and immune responses